Painful Tic Convulsif Syndrome (PTCS) is a rare syndrome in which trigeminal neuralgia (TN) and ipsilateral hemifacial spasm (HS) coexist. It is considered a debilitating disease that significantly reduces patients’ quality of life.
History: The term “painful tic convulsif” was coined by Cushing in 1920. The association between TN and HS was identified by Campbell & Keedy in 1947. In recent years, Liu et al. published a retrospective study of 40 cases in 2020, and Yin et al. published the first individual patient data meta-analysis accumulating 192 cases in 2021, clarifying epidemiological characteristics and relative frequencies of etiologies.
Epidemiology: It predominantly occurs in women aged 40–60 years and is more common on the left side. The frequency of trigeminal neuralgia itself is 4–5 per 100,000 people, more common in elderly women, while hemifacial spasm is more common in middle-aged and elderly individuals and follows a chronic progressive course. According to Liu et al., PTCS often presents initially as HS, and aging correlates with recurrence rates.
QHow rare is Painful Tic Convulsif Syndrome?
A
It is an extremely rare disease, with only 192 cases accumulated in the meta-analysis by Yin et al. in 2021. Most reports are case reports or small case series, and large-scale epidemiological data are limited.
Initially starts from the lower eyelid, spreading to the eyelid area, then to the corner of the mouth, and finally to the entire facial expression muscles.
Spasms are involuntary, irregular, and progressive, worsening with emotional states.
Patients often experience tearing on the affected side.
Characteristics of PTCS: According to Liu et al., HS occurs more frequently than TN as the initial symptom. The essential feature of PTCS is that both symptoms appear on the same side.
Clinical Findings (Findings Confirmed by Physician Examination)
Repetitive forced eyelid closure and lateral pulling of the mouth corner can induce synchronous spasms in the eyelid and mouth corner areas.
The antagonism between spasms and eyelid opening effort can sometimes lead to inability to open the eyes.
QCan PTCS be diagnosed based on eye symptoms alone?
A
Eye symptoms are not essential for the diagnosis of PTCS. The essence of diagnosis is the coexistence of TN and HS on the same side. However, an ophthalmologist may detect corneal hypoesthesia or involuntary eyelid contractions, which can trigger the diagnosis.
Example of unified pathology: Dilation of PICA may compress both the trigeminal and facial nerves simultaneously.
Tumors (8%)
Types: Meningioma, schwannoma, arachnoid cyst, skull bone abnormalities.
This is a rare cause, and data on treatment outcomes are limited.
Vascular diseases (5–6%)
Types: Aneurysm, venous malformation.
Treatment data for PTCS due to vascular disease are also limited, and further investigation is needed.
Risk factors for HS: arteriosclerosis, family history, facial nerve damage (Bell’s palsy, compression, trauma), facial trauma.
Risk factors for TN: arteriosclerosis, hypertension, trigeminal nerve damage (compression, trauma, infection), family history, aging, stress.
When the myelin-deficient area of the trigeminal nerve at its exit from the brainstem is compressed by blood vessels or tumors, hypersensitivity occurs, causing electric shock-like pain. HS occurs when the facial nerve or pons is compressed by blood vessels in the posterior cranial fossa.
Clinical diagnosis (HS): Induce synkinetic spasms by repeated forced eyelid closure and lateral pulling of the mouth corner. Confirm the cause of compression with brainstem imaging.
Clinical diagnosis (TN): Confirmed by clinical features and CT/MRI imaging. Response to medication (carbamazepine) also aids diagnosis.
Electrophysiology: EMG can detect irregular and enhanced patterns in muscles innervated by the trigeminal and facial nerves.
Imaging: Contrast-enhanced CT, MRI, CTA, and MRA evaluate the cause of compression (tumor, cyst, blood vessel).
Differentiation from other involuntary movements such as myokymia and fasciculations is also necessary. HS may go undiagnosed.
QWhy is PTCS easily overlooked?
A
TN is often misdiagnosed as dental disease, sinusitis, or migraine, and HS as tics or psychogenic disorders. Furthermore, because the coexistence of both is not easily recognized, diagnosis as PTCS is often delayed. It is important to examine with the possibility that TN and HS coexist on the same side.
First-line: Botulinum toxin therapy is currently the first-line treatment.
Subcutaneous injection of botulinum toxin type A is effective in about 90% of cases, with onset of effect in 2–3 days, duration of 3–4 months, and requires regular reinjection.
Microvascular decompression (MVD) is the standard surgical treatment for PTCS caused by vascular compression.
The offending vessel is moved away from the nerve, and a Teflon pledget or Ivalon sponge is inserted to prevent recurrence.
When vascular compression is the sole cause, MVD can relieve compression of both the trigeminal and facial nerves.
Cure rate over 80%. Cases involving AICA/PICA have higher success rates than those involving other vessels.
Advanced age is associated with a higher recurrence rate.
Other treatments: tumor/cyst resection, radiofrequency coagulation, thermocoagulation, gamma knife radiosurgery.
QCan microvascular decompression (MVD) improve both trigeminal neuralgia and hemifacial spasm?
A
When vascular compression is the single cause, MVD can relieve compression of both the trigeminal and facial nerves at once. The cure rate is over 80%, and particularly good results are obtained when the AICA or PICA is the responsible vessel.
6. Pathophysiology and detailed mechanism of onset
PTCS includes a “unified pathology” where a single lesion compresses both nerves simultaneously, and an “independent pathology” where separate lesions affect each nerve.
The facial nerve root exit zone is covered only by arachnoid membrane and lacks an epineurium. It is a transition zone from central to peripheral myelin and lacks connective tissue septa, making it vulnerable to compression.
Peripheral hypothesis: Ectopic and ephaptic excitation due to vascular compression or space-occupying lesions at the root exit zone.
Central hypothesis: Facial nerve injury leads to hyperexcitability of the facial nucleus in the brainstem.
In either mechanism, inappropriate excitation leads to involuntary muscle activation and HFS.
Example of unified pathology: Dilation of the PICA compresses both the trigeminal and facial nerves simultaneously.
Example of independent pathology: The AICA compresses the trigeminal nerve, and the facial nerve is damaged during brain surgery.
7. Latest Research and Future Prospects (Research Stage Reports)
Liu et al. (2020) showed in a retrospective study of 40 cases that PTCS more often presents as HS than TN.
Yin et al. (2021) published the first individual patient data meta-analysis of 192 cases, systematically elucidating the epidemiological characteristics, relative frequency of etiologies, and risk factors of PTCS.
Data on treatment efficacy for rare causes (tumors, cysts, vascular diseases, trauma) are currently limited, and further research is needed. The possibility of underdiagnosis of PTCS has been pointed out, and education and awareness for accurate diagnosis of TN and HS are required.
Cushing H. The major trigeminal neuralgias and their surgical treatment. Am J Med Sci. 1920.
Campbell FG, Keedy C. Hemifacial spasm: a review of the etiologic factors, with emphasis on those originating from the central nervous system. Can Med Assoc J. 1947.
Liu C, et al. Hemifacial spasm combined with ipsilateral trigeminal neuralgia (painful tic convulsif): clinical and neuroimaging characteristics in 40 patients. Neurosurgery. 2020.
Yin LX, et al. Hemifacial spasm combined with ipsilateral trigeminal neuralgia: systematic review and individual patient data meta-analysis of 192 cases. J Neurosurg. 2021.
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.